Secretion of interferon tau (IFNt) by trophoblastic tissue has been shown to be the first embryonic signal for pregnancy recognition. Therefore we tried to derive biologically active trophoblastic tissue by in vitro techniques. Since conventional in vitro conditions for bovine embryo development were not sufficient for long-term culture, we tested more complex culture conditions, including M6nezo B2 or Buffalo rat liver (BRL) cell-conditioned medium, for their ability to support proliferation and IFNt secretion by in vitro-derived trophoblastic tissue. IFNt activity was determined by using a biological assay based on the inhibition of the cytopathic effect of vesicular stomatitis virus on Madin-Darby bovine kidney cells. When cultures of individual hatched blastocysts were started in 60-pl drops of BRL cell-conditioned medium, mean IFNt secretion (antiviral units/ml/48 h) corresponded to 1200 on Day 11 and to 5000 on Day 13 (p < 0.01). To characterize trophoblast cell-specific secretions, the inner cell mass was removed from all embryos by microsurgery on Day 13. IFNT secretion by trophoblastic tissue increased to mean levels of > 105 antiviral units/ml/48 h on Day 23, stayed high for about 1 wk, and then slowly declined to levels below 10 3 antiviral U/ml/48 h. The specificity of the cytoprotective effect of IFNc was tested by Western blot analysis and by immunoneutralization with use of a polyclonal antiserum specific to IFNt. Our results demonstrate that viable trophoblastic tissue can be maintained entirely in vitro and secretes high amounts of IFNt.
INTRODUCTION
Early embryonic mortality, a major economic problem in cattle production [1] , is most probably due to pathophysiological alterations in the biochemical network of embryomaternal communication [2] . The first embryonic signal for pregnancy recognition in domestic ruminants is interferon tau (IFNt) [3] , which has high amino acid sequence homology with a-interferon [4] [5] [6] [7] and was originally named trophoblastin [8] , trophoblast protein-i [9] , or type I trophoblast interferon [10- 131. IFNt is a major secretory protein produced by the trophectoderm cells of bovine conceptuses at about Day 15 and plays a very important role in establishment of pregnancy by its antiluteolytic effect (for review, see [14] ). In addition, IFNz has potent antiviral [15] [16] [17] [18] and antiproliferative activity [19, 201. A number of studies have demonstrated that trophoblastic tissue has an antiluteolytic effect. Transfer of ex vivoderived trophoblastic vesicles to cyclic heifers resulted in a prolongation of the estrous cycle [211. Cotransfer of in vivoderived trophoblastic vesicles with frozen-thawed blastocysts [22] or embryos consisting of reduced cell numbers Accepted August 2, 1995. ReceivedJanuary 4, 1995. 'This study was supported by EC grant B102-CT92-0067 and by a grant from the Bayerische Forschungsstiftung.
2 Correspondence: Prof. Dr. Dr. habil. Gottfried Brem, Institut for Tierzucht und Genetik, VeterinArmedizinische Universitit Wien, Linke Bahngasse 11, A-1030 Vienna, Austria. FAX: 43-1-7149104. [231 increased pregnancy rate. In addition, a positive effect on embryo development of trophoblastic secretions was seen in coculture experiments of preimplantation-stage bovine embryos with trophoblastic vesicles [24, 251 . In view of these potential applications of trophoblastic cells or secretions, their production exclusively by in vitro techniques would be useful for basic studies on trophoblast cell physiology and for practical purposes as well. Since attempts using conventional systems for bovine embryo development have been unsuccessful at maintaining high levels of IFNt secretion [26] , we used more complex culture conditions-Meneizo B2 (B2) [27] and Buffalo rat liver (BRL) cellconditioned medium [28] . B2 has been used successfully for short-term culture of ex vivo-derived trophoblastic vesicles [21] . BRL cell-conditioned medium is known to promote proliferation and to inhibit differentiation of mouse embryonic stem cells [281.
In this study, we investigated effects of stage of embryo development, types of culture conditions, presence or absence of feeder cells, and duration of culture on development and IFNt secretion by bovine embryos produced in vitro or trophoblastic tissues that were maintained in vitro. Our experimental hypothesis was that prolonged viability of trophoblastic tissue and secretion of IFNT may not-as previously hypothesized [261-require a uterine environment but may be maintained by the complex culture systems described above.
MATERIALS AND METHODS

In Vitro Production (IVP) of Day 8 Bovine Blastocysts
IVP of bovine embryos was essentially carried out as previously described [291. Briefly, ovaries from nonpregnant heifers and cows were obtained from the local slaughterhouse. Oocytes were aspirated from follicles with a diameter between 2 and 6 mm. Oocytes with a complete dense cumulus and a dark, evenly granulated cytoplasm were selected for in vitro maturation (IVM). The IVM medium was Hepes/carbonate-buffered (4.43 mM Hepes/33.9 mM sodium bicarbonate) tissue culture medium 199 (TCM 199) supplemented with 2 mM sodium pyruvate, 2.92 mM calcium lactate, 10 ,gg/ml FSH (FSH-p, Schering Pharmaceuticals, Kenilworth, NJ), 60 gg/ml gentamicin (Sigma, St. Louis, MO), and 10% (v/v) heat-inactivated serum from cows at estrous (ECS). Oocytes were matured for approximately 24 h at 39°C in an atmosphere of 5% CO 2 in air and maximum humidity. For in vitro fertilization, matured oocytes (30/400 l1) were maintained in a Tyrode's-Albumin-Lactate-Pyruvate (TALP) medium containing 6 mg/ml BSA, 10 lg/ml heparin, and frozen/thawed semen (106 spermatozoa/ml) that had been subjected to a swim-up procedure described by Parrish et al. [30] . Oocytes were maintained in this medium for 20 h under the conditions that had been used for IVM. Subsequently, oocytes were cultured together with attached granulosa cells from the cumulus oophorus in TCM 199 supplemented with 10% ECS at 39C in a humidified atmosphere of 5% CO2:5% 02:90% N 2 .
On Day 8 (fertilization = Day 0), embryos were evaluated morphologically for developmental stage and quality [31] . Only excellent and good blastocysts or hatched blastocysts were used for the culture experiments described below. For statistical analysis, blastocysts and expanded blastocysts as well as hatching and hatched blastocysts were pooled. The two groups are referred to as blastocysts and hatched blastocysts.
Culture Systems for Day 8 to Day 13 Embryos and > Day 13 Trophoblastic Tissue
On Day 8, blastocysts were transferred individually to 60-pl microdrops of various media under equilibrated paraffin oil (DAB 7160; Merck, Darmstadt, Germany). Embryos were distributed among treatment groups according to a completely randomized design created by the PLAN procedure (SAS Institute Inc., Cary, NC). The culture conditions were as follows: la) TCM 199 supplemented with 10% heat-inactivated ECS; lb) Menezo B2 (ref. 01001; BioMerieux SA, Marcy-l'Etoile, France) supplemented with 15% heat-inactivated fetal bovine serum (FBS; Biochrom, Berlin, Germany); c) Dulbecco's modified Eagle's medium supplemented with 60% BRL cell-conditioned Glasgow BHK 21 medium, 10 -4 M 2-mercaptoethanol (Merck) and 15% FBS (GLCM); ld) GLCM in the presence of mitotically inactivated (,y-irradiation; 10 min; 5000 rad) primary mouse embryonic fibroblast feeder cells (GLCM/F).
Culture was carried out at 39 0 C with 5% CO 2 (a and b) or at 37°C with 10% CO 2 (c and d) in humidified air.
Different serum supplementations (ECS vs. FBS) were used, since TCM 199 is supplemented with ECS in our routine bovine embryo production system, while all other media have been used only with FBS [21, 32] . Cultures in GLCM were maintained at 37 0 C and 10% CO 2 since these conditions have been found suitable for mouse embryonic stem cells.
On Day 11 and on Day 13, 30-l samples of each drop were taken for quantification of IFNz and replaced by the same amount of fresh medium. Samples were stored individually at -20C until further analysis. From Day 13, after removal of the inner cell mass by microsurgery, 30-ll medium samples were taken from each drop every other day and replaced with fresh medium.
Estimation of Trophoblastic Cell Viability and Proliferation
To estimate the amount of trophoblastic cells, we calculated the area of trophoblastic cells after measuring the mean radius (r) of embryos, spherical trophoblastic vesicles, or attached trophoblastic tissue. Trophoblastic area was calculated as 4r 2 ic (spherical) or as r 2 tr (attached). These calculations give only an approximate estimation of trophoblastic cell growth, since embryos and trophoblastic vesicles may collapse and re-expand. However, these estimations can-in contrast to more accurate methods-be done repeatedly for prolonged periods without detrimental effects to the trophoblastic cells. Individual embryos or trophoblastic structures were evaluated morphologically and measured simultaneously with changes of medium. Embryos and trophoblastic structures that appeared dark and shrunken and did not show cell proliferation were judged to be degenerated.
Biological Assay for IFNr Bioactivity
IFNT secretion was quantified by means of a bioassay based on the inhibition of the cytopathic effect of vesicular stomatitis virus (Indiana strain) on Madin-Darby bovine kidney (MDBK; ATCC CRL-6071) cells [33] . The NIH recombinant human IFNaII reference preparation (No. Gxa01-901-535, NIH-Research Reference Reagent Note No. 31, 1984) was included in each assay. The antiviral activity was shown to be IFN, as the effects of supernatant and appropriate control IFN preparations were blocked by specific anti-IFN sera.
Immunoneutralization of IFNr
The following antisera with specific reactivity against different IFN preparations were used to demonstrate blocking of antiviral activity: 1) anti-recombinant bovine trophoblast Both antisera as well as normal rabbit serum were used in dilutions from 1:80 to 1:5120. In IFN neutralization experiments, 400 antiviral U/50 1tl of trophoblast tissue supernatants were tested in checkerboard titrations after incubation (1 h at 37C) with the different sera. ; and electrophoresed on a 5% stacking/15% separating SDS-polyacrylamide gel. Separated proteins were transferred to polylidene difluoride (PVDF) membrane (Bio-Rad, Munich, Germany). Immunodetection of IFNt was performed according to Amersham ECL (Amersham Buchler, Braunschweig, Germany) Western blot detection protocols. Briefly, the membrane was blocked in a solution of 5% BSA in PBS containing 0.1% Tween 20 (PBS-T) for 2 h, rinsed several times with PBS-T, and incubated in a 1:1000 dilution of rabbit anti-rbIFNT serum in PBS-T at 37°C for 12 h. Bound IFNt-specific antibodies were detected by means of peroxidase-conjugated goat-anti-rabbit antibodies (1:1000 in PBS-T; A9169, Sigma, Deisenhofen, Germany) and Amersham ECL detection reagents. As a control, a second blot was produced and treated identically except for the IFNrspecific antiserum, which was replaced by the same dilution of a normal rabbit serum.
Western Blot Analysis of Medium Samples for IFNr
Statistical Analysis
Developmental rates of embryos cultured in different conditions were evaluated by chi-square analysis. Trophoblastic area and IFNz production by Day 11 and Day 13 embryos were analyzed by means of a linear model, taking effects of stage of embryo development on Day 8, culture system, time in culture (= age) and all possible interactions between these factors into account. Data were transformed to natural logarithms before analysis to approximate normal distribution of values. The GLM procedure (SAS Institute Inc.) was used to calculate least squares means (LSMs), which were compared by Student's t-tests. The values presented are antilogarithms of LSMs of logarithmically transformed data. A univariate repeated-measures analysis of variance was used for the evaluation of growth and IFNT secretion by > Day 13 trophoblastic tissue to take the correlations between measurements into account. The model fitted included culture condition as well as individual trophoblastic sample within culture condition as fixed effects, and time in culture as covariate as well as the interaction between time and culture condition. Normal distribution of residual errors was tested by the Shapiro-Wilk test. Homogeneity of variances of residual errors was tested by an F test.
RESULTS
Development of lIVP Day 8 Bovine Embryos in Different Culture Systems
The numbers of blastocysts and hatched blastocysts randomly distributed among treatment groups were 10 and 20 (TCM 199), 13 and 38 (B2), 36 and 14 (GLCM), and 31 and 19 (GLCM/F), respectively. As outlined in Table 1, TCM 199 was not sufficient for culturing IVP blastocysts. On Day 11, all embryos were degenerated in this culture system. With B2 or GLCM, more than 80% of the embryos were alive on Day 11. The presence of feeder cells resulted in a significantly elevated proportion of attached embryos (p < 0.05). On Day 13, GLCM proved to be superior to B2 (p < 0.05), in which more than 40% of the embryos were degenerated. The survival rates of embryos in GLCM and GLCM/F were 80% and 82%, respectively. The effect of feeder cells on the attachment of embryos was more pronounced on Day 13 than on Day 11.
Since the proportions of blastocysts and hatched blastocysts were not homogeneous among treatment groups (chi-square analysis: p < 0.05), we used analysis of variance to estimate fixed effects of culture condition, stage of the embryo on Day 8 (blastocyst vs. hatched blastocyst), time in culture (= age), and all possible interactions between these factors on trophoblastic growth and IFNT secretion. Logarithmic transformation reduced skewness of data from 1.89 to -0.06 (trophoblastic area) and from 5.67 to 0.27 (IFNx secretion). The corresponding levels of kurtosis were 3.86 and -0.17, and 36.65 and -0.10. The results of analysis of variance are shown in Table 2 . Error variances of transformed data did not significantly deviate from normal distribution and were homogeneous among experimental groups.
Although there was no significant difference in trophoblastic area or IFN production by embryos cultured in B2, "DF = degrees of freedom; F = F value; *p< 0.05; **p < 0.01; ***p < 0.001; n.s. = not significant. #Other interactions between the main effects were not significant and were therefore omitted from the final model.
GLCM, or GLCM/F on Day 11, GLCM was superior to B2 on Day 13 with respect to both parameters (p < 0.01). The presence or absence of feeder cells did not play a significant role for trophoblastic growth and IFNT production (Fig. 1A) .
Embryos that had already hatched on Day 8 displayed greater trophoblastic growth (Day 11: p < 0.05; Day 13: p < 0.001) and IFNT secretion (Day 11: p < 0.05; Day 13: p = 0.07) than did nonhatched blastocysts (Fig. 1B) . There was a marked increase of trophoblastic area (p < 0.01 except for B2) and IFNT secretion (p < 0.01) from Day 11 to Day 13. IFNT secretion was significantly (p < 0.01) correlated with trophoblastic area under all culture conditions evaluated (Table 3) .
Growth and IFNr Secretion by IVP Trophoblastic Tissue
On Day 13, the inner cell mass was microsurgically removed from all embryos, and culture of trophoblastic tissue from individual embryos was continued in the same culture system. Antilogarithms of means of logarithmically transformed data obtained for trophoblastic growth and IFNT secretion are shown in Figure 2 . There was an increase in trophoblastic area and IFNT secretion from Day 15 to Day 23 in all culture systems. Media conditioned by feeder cells alone did not possess any antiviral activity (data not shown). Regression analysis showed that trophoblastic growth was significantly influenced by the effects of individual trophoblastic tissue within culture condition (p < 0.001), time in culture (p < 0.001), and the interaction time in culture culture condition (p < 0.01), whereas the effect of culture condition reached the borderline of statistical significance (p = 0.07). IFNT secretion was affected by individual trophoblastic tissue within culture condition (p < 0.001) and time in culture (p < 0.001). The statistical model used explained 84.4% and 84.9% of the total variation of data obtained for trophoblastic growth and IFNT production, respectively. Distribution of residual errors did not significantly deviate from normal distribution. Error variances were homogeneous among experimental groups. Regression coefficients for time in culture on logarithmically transformed data obtained for trophoblastic growth in GLCM (0.26) and GLCM/F (0.30) were significantly (p < tic tissue attached to the feeder cells, forming large sheets of trophoblastic cells (diameter up to 7.5 mm). In GLCM, trophoblastic tissue from about 50% of the embryos attached within the experimental period, whereas the remaining trophoblastic pieces displayed spherical growth.
On Day 23, trophoblastic tissue produced in GLCM or GLCM/F was frozen, but trophoblastic tissue maintained in B2 was further examined until Day 47. A few trophoblastic vesicles continued to develop until Day 39 and then started to degenerate. IFNt secretion by trophoblastic tissue in B2 reached a maximum on Day 23 and then slowly declined to reach levels below 103 antiviral U/ml/48 h on Day 43 (Fig.  3) . Representative IVP trophoblastic vesicles are shown in Figure 4 .
Western Blot Analysis of IVP Trophoblastic Secretions
Western blot analysis of medium samples conditioned by Day 23-25 IVP trophoblastic tissue revealed bIFNt-specific proteins between 21.5 and 23 kDa (Fig. 5) . The intensity of bands was consistent with the biological activity. Fresh GLCM and GLCM conditioned by feeder cells did not show a reaction with bIFNT-specific antibodies. There was no bIFNt-specific signal in B2 supplemented with 10% normal rabbit serum. The IFNt-specific bands were absent in a corresponding experiment in which the anti-IFNt serum was replaced by normal rabbit serum (data not shown).
Immunoneutralization of IFNr Produced by IVP Trophoblastic Tissue
The cytoprotective effect of IVP trophoblastic secretion (400 antiviral U/50 l) was completely neutralized by a 1:80
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_ _ dilution of an antiserum to rbIFNt but not by an antiserum to human IFNa or by normal rabbit serum (data not shown).
DISCUSSION
The aim of our study was to establish culture conditions in which IFNT-secreting trophoblastic tissue can be generated and maintained in vitro. When IVP blastocysts were cultured in TCM 199 supplemented with 10% FBS, they secreted only small amounts of IFNT and degenerated [26] . This is consistent with our findings that TCM 199 is not sufficient to maintain later-stage embryos in culture. When blastocysts were transiently transferred to the uteri of synchronized cows, recovered 4 days later, and then cultured, they survived in vitro and started to produce high amounts of IFNT [26] . The authors concluded that blastocyst viability and sustained IFNT secretion may require some exposure to a uterine environment. Our study was based on the assumption that later-stage blastocysts may require more complex culture conditions than TCM 199. Therefore we chose Menezo B2, which has already been used for the culture of ex vivo-derived bovine trophoblastic tissue [21] , and BRL cell-conditioned medium, which was used to maintain mouse embryonic stem cells in culture [28] . We have shown that BRL cell-conditioned medium markedly stimulates the proliferation of mouse embryonic stem cells but inhibits their differentiation less efficiently than the purified cytokines leukemia inhibitory factor (LIF), ciliary neurotrophic factor, and oncostatin M [32, 34] . BRL cells are known to produce a plethora of growth factors including LIF [28] , insulin-like growth factor-II [35] , and transforming growth factor [3 [36] . BRL cell-conditioned medium has successfully been used for in vitro production of bovine embryos [371. Addition of purified LIF to the medium has been shown to increase hatching rate and trophectoderm growth of mouse preimplantation embryos in culture. Similar results were obtained with ovine embryos (for review, see [38] ).
High production of IFNt by IVP trophoblastic tissue in both B2 and BRL cell-conditioned media suggests that a stimulation of trophoblastic cells by a uterine environment is not absolutely necessary.
In addition to the culture condition, the developmental stage of the embryo and the presence or absence of feeder cells significantly influenced trophoblastic growth and IFNT secretion.
When embryo cultures were started with hatched Day 8 blastocysts, trophoblastic growth and IFNT secretion was significantly greater than when nonhatched Day 8 blastocysts were used as starting material. This is consistent with findings by Hernandez-Ledezma et al. [39] that IFNT secretion is positively correlated with embryo quality or developmental stage.
Use of feeder cells together with BRL cell-conditioned medium significantly increased the proportion of attached embryos on Day 11 and Day 13 but did not affect embryonic IFNz secretion. After removal of the inner cell mass on Day 13, trophoblastic growth and IFNt production were greatest in the presence of feeder cells. Feeder cells may act unspecifically by providing a mechanically suitable substrate for other cells or by detoxification of medium. On the other hand, they may secrete specific growth factors that stimulate cell proliferation and protein synthesis [40] .
Since cryopreservation would greatly facilitate the prac- tical use of IVP trophoblastic tissue for cotransfer with embryos, we stopped culture experiments in GLCM on Day 23 and froze the trophoblastic tissue. Our preliminary results indicate that IVP trophoblastic tissue may survive cryopreservation and secrete high levels of IFNT after thawing; however, the viability is markedly influenced by the amount of frozen tissue [41] . Therefore, only large pieces (> 500 pm in diameter) of trophoblastic tissue should be used for cryopreservation.
Long-term cultures in B2 indicated that IVP trophoblastic vesicles may survive until Day 47 in culture. IFN secretion reached a maximum on Day 23 and then slowly declined to reach levels below 10 3 antiviral U/ml/48 h on Day 43. In vivo, IFN synthesis is maximum between Days 16 and 19 but can be detected from Day 12 and until at least Day 38 [42, 43] of pregnancy. The phenomenon of a later increase of IFN secretion to maximum levels in vitro needs to be clarified. Since we removed the inner cell mass on Day 13, this increase could be due to lack of factors produced by the inner cell mass that might down-regulate IFN secretion. However, the level and timing of IFN secretion was very similar in intact nuclear transfer embryos that were cultured for up to 24 days [44] . Thus differences between the timing of trophoblastic secretions in vivo and in vitro are more likely to be due to uterine factors and/or factors provided by the culture medium.
The specificity of antiviral activity produced by IVP trophoblastic cells was shown by Western blot analysis using an antiserum raised against rbIFN and by immunoneutralization tests. Western blot analysis revealed bIFNt immunoreactive proteins in the range of 21.5-23 kDa, which is consistent with findings by other investigators [18, 42, 45, 46] . Furthermore, the antiviral activity could be neutralized by an antiserum to rbIFN but not by an antiserum to human IFNa or normal rabbit serum. This is consistent with experiments involving immunoneutralization of rb-IFN [47] .
In summary, our results demonstrate that trophoblastic tissue secreting high amounts of biologically active IFNt can be generated and maintained in vitro. Transfer and cotransfer experiments are in progress to investigate whether IVP trophoblastic tissue can inhibit luteolysis and support the in vivo development of frozen-thawed embryos or embryos with reduced cell numbers. Six recipients each received an IVP trophoblastic vesicle and an in vivo-flushed embryo. All recipients became pregnant. These preliminary results indicate that cotransfer of IVP trophoblastic tissue at least does not disturb the establishment of a pregnancy.
